Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:57 am Purchase |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Deep Track Capital, LP | 2,727,606 6.500% |
627,606 (+29.89%) |
Filing History |
| 2023-02-14 08:56 am Purchase |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,837,818 9.430% |
356,818 (+14.38%) |
Filing History |
| 2023-02-14 08:53 am Sale |
2022-12-31 | 13G | Passage Bio, Inc. PASG |
Deep Track Capital, LP | 0 0.000% |
-3,216,997 (Position Closed) |
Filing History |
| 2023-02-14 08:52 am Sale |
2022-12-31 | 13G | Nuvation Bio Inc. NUVB |
Deep Track Capital, LP | 8,221,188 3.760% |
-3,250,093 (-28.33%) |
Filing History |
| 2023-02-14 08:50 am Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,266,569 4.810% |
-169,595 (-6.96%) |
Filing History |
| 2023-02-14 08:50 am Sale |
2022-12-31 | 13G | Nkarta, Inc. NKTX |
Deep Track Capital, LP | 1,354,200 2.770% |
-611,484 (-31.11%) |
Filing History |
| 2023-02-14 08:47 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 3,000,000 4.950% |
-1,870,000 (-38.40%) |
Filing History |
| 2023-02-14 08:45 am Sale |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Deep Track Capital, LP | 0 0.000% |
-917,825 (Position Closed) |
Filing History |
| 2023-02-14 08:44 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
Deep Track Capital, LP | 0 0.000% |
-3,362,000 (Position Closed) |
Filing History |
| 2023-02-14 08:42 am Purchase |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Deep Track Capital, LP | 3,000,000 4.690% |
247,930 (+9.01%) |
Filing History |
| 2023-02-14 08:41 am Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 0 0.000% |
-1,500,000 (Position Closed) |
Filing History |
| 2023-02-14 08:40 am Purchase |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
Deep Track Capital, LP | 4,259,653 8.240% |
259,653 (+6.49%) |
Filing History |
| 2023-02-14 08:39 am Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
Deep Track Capital, LP | 7,878,119 5.880% |
-1,121,881 (-12.47%) |
Filing History |
| 2023-02-14 08:38 am Unchanged |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Deep Track Capital, LP | 3,250,000 8.050% |
0 (Unchanged) |
Filing History |
| 2023-02-14 08:37 am Purchase |
2022-12-31 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 9,710,000 7.520% |
2,929,173 (+43.20%) |
Filing History |
| 2023-02-14 08:36 am Unchanged |
2022-12-31 | 13G | Immunic, Inc. IMUX |
Deep Track Capital, LP | 4,022,989 8.320% |
0 (Unchanged) |
Filing History |
| 2023-02-14 08:35 am Sale |
2022-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
Deep Track Capital, LP | 124,037 2.370% |
-379,563 (-75.37%) |
Filing History |
| 2023-02-14 08:34 am Sale |
2022-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Deep Track Capital, LP | 0 0.000% |
-3,646,690 (Position Closed) |
Filing History |
| 2023-02-14 08:34 am Sale |
2022-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Deep Track Capital, LP | 0 0.000% |
-2,686,655 (Position Closed) |
Filing History |
| 2023-02-14 08:32 am Purchase |
2022-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 2,656,901 8.200% |
756,901 (+39.84%) |
Filing History |